The aim of the present study was to compare cardiac hypertrophy and diastolic function in extremely obese male patients and physically active adult male subjects of similar age (means 43.0-43.4 y). DESIGN: Data of male patients referred to our hospital ward in order to reduce their body weight (BW) were compared with those of physically active and nonactive healthy males. SUBJECTS: The groups contained 21-24 male subjects, very active and moderately active subjects taking part in regular competitive or leisure time physical activity were in the two athletic groups, severely overweight patients constituted the obese group and healthy persons served as controls. MEASUREMENTS: Two-dimensionally guided M-mode and Doppler recordings. RESULTS: In comparison with the controls, obese patients had larger left atrial systolic and left ventricular (LV) diastolic internal diameters, LV diastolic wall thickness and muscle mass. Of the body size-related indices, only the left atrial systolic diameter index was significantly higher. LV systolic and diastolic functions were impaired as indicated by a decreased ejection fraction (EF), higher heart rate (HR), decreased E/A quotient and increased isovolumetric relaxation time. In the physically very active subjects, a thicker LV diastolic wall was seen without LV dilatation. Body size-related wall thickness and muscle mass were significantly higher than in the controls. EF and HR did not differ from those of the controls. CONCLUSION: The most useful help to distinguish between physiological and pathological left ventricular hypertrophy can be to investigate diastolic functions. The most salient difference appeared in diastolic function, because E/A quotient was higher in the very active subjects than in the controls and it was the lowest in the obese persons.
Introduction
Association between obesity and left ventricular (LV) hypertrophy has received markedly increased attention recently. LV hypertrophy itself is considered an independent cause in cardiovascular morbidity and mortality, and has been assigned a very important role in sudden cardiac death. 1, 2 Secondary LV hypertrophy can be caused by many different factors. Undoubtedly, one of these causes is obesity. Excessive body weight, the blood supply of surplus of adipose tissue mass means an additional burden on the heart, especially on the LV muscle. [1] [2] [3] [4] [5] Cardiac overload can occur also in persons with a normal body weight and can induce LV hypertrophy as well; for example, in hypertension where usually increased total peripheral resistance persists that in the long run overburdens the heart.
Since obesity and hypertension often coexist, one might assume that LV hypertrophy of obese patients is mainly caused by hypertension. However, data provided by the Framingham Heart Study 7 as well as our earlier observations 5, 8 showed that the increase of LV muscle mass (LVM) in obese patients was independent of hypertension. Cardiac hypertrophy in obese patients can instead be explained by a higher incidence of insulin resistance and consequent hyperinsulinaemia that can directly lead to myocardial hypertrophy mediated by the insulin-like growth factor (IGF-1). 5, 7, 9 The physiological type of LV hypertrophy can be observed as an adaptation to regular physical training in physically active individuals with a normal body weight (BW). Echocardiographic data of the last decades indicate that in these cases both LV wall thickness and LV volume increase. [10] [11] [12] [13] [14] [15] [16] [17] [18] Hence, it is not easy to evaluate cardiac hypertrophy. It can be the result of an illness, of a pathological state, but in other cases it can be interpreted as a positive outcome of a healthy, physically active lifestyle. In young people with a normal body weight, especially in physically active people, the hypertrophy of the left ventricle is unambiguously favourable, being a sign of high endurance capacity. In older people, it is more difficult to assess the role of hypertrophy. Based on sports cardiologic studies 15, [19] [20] [21] [22] [23] [24] made in the last few years, the two types of hypertrophy can be best separated functionally, primarily by using the parameters of diastolic function.
The aim of our present study was to compare the cardiac hypertrophy and functions of severely obese, middle-age men with data of physically well-trained active men of the same age.
Subjects and methods

Subjects
The subjects' characteristics are shown in Table 1 . Subjects with lower than 155 mmHg systolic and 100 mmHg diastolic blood pressures only were enrolled in the study. The three nonobese groups only comprised subjects with body mass index (BMI)o30 kg/m 2 . The range of BMI is given for each group in Table 1 . The physically active group was divided into two subgroups. Members of the physically very active group were engaged in sports activity more than 7 h per week, several of them participated in competitions or matches. Seven trackand-field athletes, seven game players (tennis, handball, water polo and ice-hockey), 1-1 triathlonist, orienteering runner, swimmer and power athlete, and four leisure-timeathletes not attached to any definite branch of sports belonged to this group. The members of the physically active group were less active athletes; they had 3-6 h of physical training a week. Nine members of this group were involved in ball-games (tennis, basketball, soccer and waterpolo), two in swimming, two in track-and-field running, while 11 subjects were not definitely attached to any branch of sports. The control group consisted of healthy volunteers engaged in mental work or in the business life without any regular sports activity and with a normal BW. The members of the obese group were male patients who were referred to our hospital ward in order to reduce their BW and had no other illness so they did not get any medication.
In some subjects relatively higher blood pressure was actually found during the measurements, but they did not know about their hypertension disease and had not got any medication before the study. Higher than 140/90 mmHg blood pressure was measured in four very active, three active, six control, and 10 obese subjects.
The four different groups were of the same age. Mean body height (BH) of the very active group was slightly higher than that of the control group. The obese group had significantly larger mean BW, BMI, and body surface area (BSA) than the other groups.
Methods
Echocardiography using a Dornier AI 4800 Doppler echocardiograph with a 2.5 MHz transducer was carried out with the subject at absolute rest. Two-dimensionally guided Mmode recordings were obtained parasternally observing the recommendations of the American Society of Echocardiography. 25 Measurements of LV wall thickness and internal diameter were obtained by positioning the trackball cursor on the screen. Early (E) and late (A) diastolic peak filling velocities were estimated by pulse wave Doppler measurements in the four-chamber apical view. All measurements Differences in cardiac hypertrophy Z Sidó et al were performed by the same investigator. Values were measured across 10 cardiac cycles, results were accepted only when they were very similar to each other (less than 5% difference), and means of at least three cycles were used in the further analysis. Peak velocity was calculated by using the highest velocity values. Left ventricular wall diastolic thickness (LVWDT) was obtained as the sum of interventricular septum diastolic thickness (IVSDT) and posterior wall diastolic thickness (LVPWDT). LVM was calculated by cubing the respective diameters 25 as:
, where LVIDD is LV internal diastolic diameter and 1.05 is the density of the cardiac wall. As a relative parameter, the quotient LV end-diastolic WT/ID was also calculated. On the basis of our 15, 26 and other previous studies, 27,28 the following exponent-corrected indices were used to relate cardiac measures to body size:
. End-diastolic and end-systolic volumes used to calculate the ejection fraction (EF) were calculated by raising the different diameters to the third power. 25 
Statistics
All statistical analyses were performed by using SPSS for Windows v. 6.0 software (SPSS, Tulsa, OK, USA). Group differences were analysed via one-way ANOVA (independent groups) with Tukey post hoc tests, differences were accepted when significant at the 0.05 level of random error or better.
Results
The upper third of the Table 2 shows the measured cardiac parameters, the middle third shows some calculated values, and the lower third shows the body size-related cardiac parameters.
The absolute means of the left ventricular wall thicknesses (IVSDT and LVPWDT) and of their sum (LVWDT ¼ IVSDT+LVPWDT) were not significantly different in the obese and the physically active groups, but in the very active and in the obese groups they were significantly higher than in the control group. Only the obese group had a larger LVIDD, the physically active and inactive subjects of normal BW showed similar mean values. The ratio of wall thickness to the internal diameter (WT/ID) was higher in the very active group than in the control group. The mean LVM of the obese group exceeded not only that of the controls, but also that of the physically active group. The LVM of the very active persons was also higher than that of the sedentary persons.
There was a significant difference between the left atrial systolic diameters (LASD): in the obese group, the mean was much higher than in the physically active and control groups. The means of the other three groups were similar to each other.
LVWDT/BSA 1/2 (LVWDT i ) was thicker in the physically very active group than in the other three groups. LVIDD i did not show any significant difference in the four groups. Mean LVM i was the highest in the very active group; differences from the controls and from the active group were significant. LASD i was higher in the obese group than in all the others, while there was no difference between the physically active and control groups. Data referring to the function of the heart are shown in Table 3 . Resting heart rate was significantly higher in the obese group than in the other three ones, there were no differences between the control and physically trained groups. Mean systolic blood pressure was higher in the obese group than in the physically active ones. No difference was seen in the respective means of diastolic blood pressure. EF Differences in cardiac hypertrophy Z Sidó et al was significantly lower in the obese group; there was no difference between the physically active and control groups. Early diastolic peak filling velocity (E) was the lowest in the obese group; late diastolic peak filling velocity (A) was higher in the obese persons than in the athletes, and also higher in the controls than in the physically very active group. As a consequence, the mean E/A ratio in the obese group was by far the lowest one, the difference being significant in comparison with all the other groups. The highest values were seen in the very well-trained men, their mean E/A was significantly higher than not only that of the obese but also than those of the control and active groups.
IVRT in the obese group tended to be longer than in the other ones, significant differences were seen in comparison with the control group and with the active group.
Discussion
The present study investigated cardiac morphologic and functional properties in subjects with two different types of cardiac hypertrophy, namely the one characteristic of severely obese subjects and another specific to physically active male subjects. The data were also compared with those of nonobese healthy men.
Both obesity and regular physical activity were associated with larger dimensions of the heart: LVWDT was similar in the two groups, LVIDD was larger only in the obese group, but not in the physically active groups. Mean LASD was markedly larger in the obese subjects, but it only tended to be larger in the physically active groups.
Observations referring to the physically active groups were similar to those made in our previous studies and in metaanalyses of other authors in that in adults the increase of LV wall thickness was much more marked than the increase of the internal diameter. 13, 15, 29 Other authors, however, reported larger LVIDD also in obese patients, indicative of the weakness and dilatation of the left ventricle rather than of a hypertrophy. 1, 2, 30, 31 The left ventricle is presumably overloaded by the increased venous inflow, the same is reflected also by the marked dilatation of the left atrium. This explanation seems to get further support from the relative, that is, body size-related indices. These indices should take account of the real demand for cardiac pumping function, that is, the blood supply of the body. While it is still usual to assess cardiac work related to BSA, we preferred to relate these parameters to size by using indices conforming to the principle of identical exponents. 15, 26, 27, 28 In these relative parameters, mean left ventricular data of the obese group did not exceed any of the control group, but they were not significantly smaller either. In the physically active groups, relative hypertrophy was conspicuous: both mean LVWDT i and LVM i were significantly higher in the physically very active group than in the controls or in the obese persons. These differences in the relative LV parameters can be very easily explained if one takes into account that the increased burden on the heart in a physically active subject is due to a regularly repeated functional overload, while in obese persons excessive body mass results in an overload. These relative indices do not rule out the assumption that in our cases the mass of the left ventricle was proportional to that of the body. The marked difference between the two types of hypertrophy manifested itself also in the WT/ID ratio, since F as in other reports 1,2 F indicating an eccentric hypertrophy in the obese patients it was similar to that of the controls, while in the physically very active group it was much higher, indicative of a concentric type of hypertrophy instead. The only relative parameter in which the obese group showed a significantly higher value than all the other groups was the relative size of the left atrium, LASD i , speaking for the fact that increased venous inflow represented a demand the heart was unable to satisfy. Our results are in accordance with those of Gottdiener et al 1997, 32 according to which obesity is the strongest predictor of left atrial size. The impairment becomes manifest in atrial congestion, and ventricular dilatation or eccentric hypertrophy. It cannot be ruled out that this dilated or eccentrically hypertrophied Differences in cardiac hypertrophy Z Sidó et al left ventricle is able to produce only a smaller EF. In obese persons, a materially increased resting cardiac output is necessary that might be provided by a substantial increase in heart rate.
In accordance with several other reports, 9, 30, [33] [34] [35] our data suggest that the diastolic function of severely obese people is also markedly impaired, as in obese people early diastolic peak filling velocity is decreased and late peak velocity is higher, so the E/A ratio becomes smaller. An elongation of IVRT also suggests an impairment of the diastolic function, since heart rate was higher in the obese persons; thus, the duration of the whole cardiac cycle was shorter. In obesity, decreased left ventricular compliance is very likely to also contribute to a decreased systolic function. Diastolic function has been shown to relate inversely to heart rate. 36, 37 One may hypothesize, therefore, that differences in diastolic function (better diastolic function of the very active and active groups, impaired relaxation ability of the obese persons) are not due to an active way of life or to obesity, but to the slower heart rate in the athletic males and to the faster heart rate in the obese persons. In our subjects, heart rate was 29% slower in the very active, 20% slower in the active, and 19% slower in the control groups than in the obese one. However, differences in the mean E/A quotient were much larger than that (E/A was larger by 86% in the very active, by 53% in the active, and by 47% in the control groups than in the obese persons). Furthermore, there were intergroup differences in the E/A quotient without significant differences in heart rate (control and active groups vs the very active one). Hence, improvement or impairment of diastolic function cannot be explained merely by a difference in cardiac frequency, some independent effect must also be involved.
Summary conclusions
(1) Long-lasting, severe obesity results in an overburden of the heart and leads to a sort of LV hypertrophy that may appear to resemble the one brought about by regular physical activity. (2) There are considerable differences, however, between the several referenced characteristics of physiological and pathological hypertrophy. 16, 38 The most important differences between pathological and physiological hypertrophy found in our study were: K LV wall thickness was similarly large in the two types of cardiac overload, but a definite increase in LVIDD was seen only in the obese group; *a definite increase of LAD was only seen in the obese group; K lower EF and higher heart rate was only seen in the obese group but not in the physically active groups; K diastolic function was poorer in the obese group, but definitely better in the physically active subjects.
(3) The beneficial effect of regular physical activity can also be supported by the observation that in some parameters physically very active subjects displayed even better results than physically active subjects, as only parameters of the very active group differed significantly from those of control (LVWDT, LVWDT i , LVM i , SBP, A) or obese (LVWDT i , SBP) groups. (4) On the basis of these data, to distinguish between physiological and pathological LV hypertrophy, the most useful help is to investigate diastolic functions. (5) To avoid the harmful consequences of obesity, any diastolic dysfunction should be detected at the earliest possible time and further deterioration impeded by starting a complex antiobesity treatment (reducing calorie input, increasing physical activity, maintaining low-salt diet, administering when necessary, also antihypertensive agents).
